| Annual Financials | 2020 | 2021 | 2022 | TTM |
Revenue  | 216 | 249 | 342 | 0 |
| Expenses | 176 | 194 | 264 | 0 |
| EBITDA | 40 | 55 | 79 | 0 |
| Operating Profit % | 17 % | 20 % | 22 % | 0 % |
| Depreciation | 11 | 13 | 14 | 0 |
| Interest | 14 | 14 | 11 | 0 |
| Profit Before Tax | 15 | 29 | 54 | 0 |
| Tax | 4 | 8 | 12 | 0 |
| Net Profit | 11 | 21 | 42 | 0 |
| EPS in ₹ | 4.11 | 7.92 | 5.22 | 0.00 |
GPT Healthcare
GPT Healthcare
147.99
+0.98
(0.67%)
Market Cap
1,214.30 Cr
EPS
5.22
PE Ratio
25.82
Dividend Yield
2.67 %
Industry
Healthcare Services52 Week High
192.00
52 Week Low
126.10
PB Ratio
6.14
Debt to Equity
0.76
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
Company News
View All News
GPT Healthcare Appoints Shree Gopal Tantia as Director Following Executive Chairman's Demise
3 days ago
3 days agoGPT Healthcare Ltd announced the appointment of Mr. Shree Gopal Tantia as an Additional Non-Executive Non-Independent Director following the demise of Executive Chairman Shri Dwarika Prasad Tantia. The company's board approved several key decisions including alterations to its Articles of Association and reconstitution of the Corporate Social Responsibility Committee. The new CSR Committee will be chaired by Dr. Om Tantia, with Dr. Aruna Tantia and Dr. Tapti Sen as members. Mr. Shree Gopal Tantia, aged 60+ years, is a promoter with over 40 years of experience in infrastructure and civil construction. The company has also approved a postal ballot notice seeking shareholder approval for Tantia's appointment and the Articles of Association changes. The board meeting was held on September 24, 2025.
GPT Healthcare Limited announced the death of Shri Dwarika Prasad Tantia, Executive Chairman and Promoter, on August 17, 2025. Tantia held 300 shares in the company and served as Chairman of both GPT Healthcare and the GPT Group. He also held the position of Honorary Consul of the Republic of Ghana in Kolkata. The company described his death as sudden and unexpected, calling it an irreparable loss. GPT Healthcare stated that operations and prospects remain unchanged and committed to upholding his legacy while continuing the mission and values he established.
GPT Healthcare Reports 9.5% Revenue Growth to INR107 Crores in Q1 FY26, Opens New 158-Bed Raipur HospitalAug 09, 2025
Aug 09, 2025GPT Healthcare Limited reported revenue from operations of INR107 crores for the first quarter, representing 9.5% growth. EBITDA stood at INR18.9 crores with a 17.9% margin, impacted by initial losses of approximately INR4.5 crores from the new Raipur hospital. Excluding these losses, EBITDA margin would be around 22%. Profit after tax was INR7.7 crores with a 7.7% margin. The company commissioned a 158-bed facility in Raipur on May 2, 2025, under an asset-light model, bringing total bed capacity to 719 beds across five hospitals. The Raipur hospital achieved 7% occupancy in 1.5 months with ARPOB of INR39,180. Network-wide bed occupancy stands at 42% due to the new hospital addition. ALOS improved to 3.4 days from 3.54 days, and ARPOB was INR38,913. The company signed an MoU for a 150-bed hospital in Jamshedpur with INR60 crores investment, expected to be commissioned by end of calendar year 2026. Management expects EBITDA breakeven for Raipur hospital in 12-15 months and targets reaching 1,000 beds within 2 years.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,123.40 | #1 1,09,211.00 | 91.03 | 7,184.10 | #1 28.68 | 1,076 | 30.34 | 38.75 | |
7,510.00 | 1,07,982.30 | 68.57 | #1 21,994.30 | 14.76 | #1 1,505 | 39.78 | 42.87 | |
932.75 | 70,418.70 | 76.18 | 7,849.70 | 13.25 | 809 | #1 53.33 | 50.92 | |
1,725.00 | 35,252.20 | #1 44.56 | 5,575.00 | 12.29 | 790 | -2.38 | 39.23 | |
1,299.70 | 34,908.30 | 61.28 | 3,771.40 | 12.59 | 481 | 49.58 | 43.43 | |
625.10 | 32,387.70 | 90.59 | 4,286.70 | 15.12 | 337 | -98.18 | 58.09 | |
726.70 | 29,078.10 | 78.90 | 3,067.00 | 21.98 | 415 | -10.71 | 45.36 | |
1,361.80 | 13,829.30 | 53.71 | 1,566.90 | 17.46 | 244 | 35.52 | 24.06 | |
1,510.40 | 9,903.10 | 51.34 | 1,290.20 | 17.77 | 194 | -1.57 | 70.90 | |
647.40 | 9,025.80 | 244.98 | 2,257.70 | 17.03 | 49 | -55.88 | 46.29 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
37.57 %
Net Income Growth
97.63 %
Cash Flow Change
53.50 %
ROE
67.13 %
ROCE
54.46 %
EBITDA Margin (Avg.)
3.97 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 |
| Total Assets | 309 | 317 | 323 |
| Fixed Assets | 226 | 220 | 220 |
| Current Assets | 63 | 86 | 86 |
| Capital Work in Progress | 2 | 0 | 1 |
| Investments | 1 | 1 | 10 |
| Other Assets | 80 | 97 | 92 |
| Total Liabilities | 309 | 317 | 323 |
| Current Liabilities | 65 | 60 | 69 |
| Non Current Liabilities | 117 | 123 | 97 |
| Total Equity | 127 | 134 | 158 |
| Reserve & Surplus | 69 | 76 | 78 |
| Share Capital | 18 | 18 | 80 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 |
| Net Cash Flow | -1 | 4 | 4 |
| Investing Activities | -54 | -17 | -5 |
| Operating Activities | 42 | 43 | 66 |
| Financing Activities | 12 | -22 | -57 |
Share Holding
| % Holding | Oct 2021 | Oct 2023 | Feb 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 99.97 % | 67.34 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 6.68 % | 5.38 % | 4.70 % | 4.72 % | 4.48 % | 4.96 % |
| DIIs | 0.00 % | 0.00 % | 10.07 % | 12.81 % | 13.08 % | 11.99 % | 11.30 % | 11.35 % | 9.32 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 17.14 % | 12.16 % | 13.61 % | 15.07 % | 15.33 % | 15.55 % | 16.65 % |
| Others | 0.03 % | 32.66 % | 7.22 % | 2.78 % | 2.35 % | 2.66 % | 3.08 % | 3.04 % | 3.50 % |
| No of Share Holders | 9 | 9 | 9 | 76,664 | 71,293 | 74,737 | 70,147 | 68,365 | 67,060 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5 | 3.5 | 2.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.84 | 2.38 | 1.69 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 02 Apr 2024 |  Dividend | ₹ 1.00 /share | 02 Apr 2024 | 167.25 | 177.30 |
| 18 Jul 2024 | Dividend | ₹ 1.50 /share | 18 Jul 2024 | 162.50 | 170.95 |
| 25 Jul 2024 |  Annual General Meeting | NA | 25 Jul 2024 | 162.50 | 167.99 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 173.64 | 163.54 |
| 28 Nov 2024 | Dividend | ₹ 1.00 /share | 28 Nov 2024 | 163.54 | 173.98 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 178.93 | 161.60 |
| 23 May 2025 | Quarterly Result Announcement | NA | 23 May 2025 | 156.88 | 155.00 |
| 29 Jul 2025 | Dividend | ₹ 1.50 /share | 29 Jul 2025 | 155.00 | 159.63 |
| 05 Aug 2025 | Annual General Meeting | NA | 05 Aug 2025 | 155.00 | 183.40 |
| 06 Aug 2025 | Quarterly Result Announcement | NA | 06 Aug 2025 | 161.35 | 180.01 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
1 day agoClosure of Trading Window1 day ago
1 day agoIntimation Regarding 100 Days Campaign-Saksham Niveshak1 day ago
1 day agoShareholder Meeting / Postal Ballot-Notice of Postal Ballot1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Change in Directorate3 days ago
3 days agoBoard Meeting Outcome for Outcome Of Board Meeting Held On September 24 20253 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2025
Sep 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 09, 2025
Aug 09, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 06, 2025
Aug 06, 2025Results- Unaudited Financial Results For The 1St Quarter Ended June 30 2025.Aug 06, 2025
Aug 06, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On August 6 2025Aug 06, 2025
Aug 06, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 28, 2025
Jul 28, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Along With Limited Review Report Of The Statutory Auditors Thereon Of The Company For The 1St Quarter Ended June 30 2025.Jul 28, 2025
Jul 28, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Jul 15, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 14, 2025
Jul 14, 2025Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The CompanyJul 12, 2025
Jul 12, 202536Th Annual General Meeting To Be Held On Tuesday August 5 2025Jul 12, 2025
Jul 12, 2025Reg. 34 (1) Annual Report.Jul 12, 2025
Jul 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 24, 2025
May 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 24, 2025
May 24, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 24, 2025
May 24, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 23, 2025
May 23, 2025Corporate Action-Board approves DividendMay 23, 2025
May 23, 2025Corporate Action-Fixes Book Closure For 36Th Annual General Meeting.May 23, 2025
May 23, 2025Results-Financial Results For The Q4FY2025May 23, 2025
May 23, 2025Board Meeting Outcome for Board Meeting Outcome Held On May 23 2025May 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
May 21, 2025Board Meeting Intimation for Considering Inter Alia Audited Financial Results For The Quarter And Year Ended March 31 2025.May 14, 2025
May 14, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (LODR Regulations)May 11, 2025
May 11, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (LODR Regulations)May 02, 2025
May 02, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (LODR Regulations)-Change In The Correspondence Details Of Registrar And Share Transfer Agent (RTA) Of The CompanyApr 18, 2025
Apr 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Apr 10, 2025Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 28, 2025
Mar 28, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 21, 2025
Mar 21, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Feb 14, 2025Technical Indicators
RSI(14)
Neutral 37.65
ATR(14)
Less Volatile 4.20
STOCH(9,6)
Oversold 10.07
STOCH RSI(14)
Oversold 6.74
MACD(12,26)
Bearish -0.26
ADX(14)
Weak Trend 20.95
UO(9)
Bullish 28.71
ROC(12)
Downtrend And Accelerating -5.30
WillR(14)
Oversold -82.90
Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Axis Multi Asset Allocation Direct Plan -Growth | 0.03% | -388771 | -0.46% | -0.38% | |
| Axis Balanced Advantage Fund Direct-Growth | 0.00% | -15449 | -0.01% | -0.01% | |
 Bandhan Retirement Fund Direct-Growth | 0.00% | -6521 | -0.06% | -0.05% | |
| Bandhan BSE Healthcare Index Fund Direct-Growth | 0.03% | -1 | -0.01% | 0.00% | |
| Axis Value Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
| Bandhan Infrastructure Fund Direct Plan-Growth | 0.68% | 0 | -0.10% | 0.06% | |
| Bandhan Small Cap Fund Direct-Growth | 0.14% | 0 | -0.03% | -0.03% | |
 Kotak Equity Savings Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
| Kotak Healthcare Fund Direct - Growth | 0.00% | 0 | 0.00% | 0.00% | |
| Kotak Multi Asset Allocation Fund Direct - Growth | 0.00% | 0 | 0.00% | -0.11% | |
| Kotak Small Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
